Furthermore, a pan-cancer analysis of the TCGA data [54, 55] revealed that while Myc amplification is associated with poor prognosis, the presence of SETX missense mutations is linked to improved outcomes in Myc-amplified tumors (Supplementary Fig. 16b, c). This evidence concerns the gene SETX and cancer.